Assignee
MAX DELBRUECK CENTRUM
DE·25 granted patents·12 pending applications·227 citations·filing 1995–2013
Top patents by PatentIndex Score
37 records- 0179US6399348B1DNA sequences for matrix metalloproteases, their production and useMAX DELBRUECK CENTRUM·Filed 2000·Granted Jun 4, 2002·8 cites·17 claims
- 0277US7342094B1Tumor vaccines for MUC1-positive carcinomasMAX DELBRUECK CENTRUM·Filed 2000·Granted Mar 11, 2008·11 cites·10 claims
- 0373US6090955ALiposome-encapsulated taxol, its preparation and its useMAX DELBRUECK CENTRUM·Filed 1995·Granted Jul 18, 2000·47 cites·16 claims
- 0471US7067474B1Agents for treating human illnesses based on β-catenin, and the production and use thereofMAX DELBRUECK CENTRUM·Filed 2000·Granted Jun 27, 2006·11 cites·5 claims
- 0566US7868185B2Shp-2 inhibitors and pharmaceutical compositions comprising themMAX DELBRUECK CENTRUM·Filed 2006·Granted Jan 11, 2011·2 cites·18 claims
- 0666US7297535B2Use of the human LRP/MVP promotor for a vector that can be induced by therapyMAX DELBRUECK CENTRUM·Filed 2001·Granted Nov 20, 2007·1 cites·7 claims
- 0765US9213028B2Method and kit for rapid isolation of human Foxp3+ Treg cellsMAX DELBRUECK CENTRUM·Filed 2013·Granted Dec 15, 2015·1 cites·8 claims
- 0865US6251365B1Specific magnetosome, method for the production and use thereofMAX DELBRUECK CENTRUM·Filed 1999·Granted Jun 26, 2001·37 cites·15 claims
- 0965US6207133B1Anti-tumoral therapy agent containing a contrast agentMAX DELBRUECK CENTRUM·Filed 1998·Granted Mar 27, 2001·41 cites·11 claims
- 1063US7049336B2Method for diagnosing neuronal diseases and for treating primary hemostasis deficiencyMAX DELBRUECK CENTRUM·Filed 2001·Granted May 23, 2006·6 cites·8 claims
- 1159US6039941ALive vaccine for the treatment of tumor diseasesMAX DELBRUECK CENTRUM·Filed 1995·Granted Mar 21, 2000·17 cites·17 claims
- 1258US6881577B2Method for improving transfection efficiencyMAX DELBRUECK CENTRUM·Filed 2001·Granted Apr 19, 2005·1 cites·6 claims
- 1358US6114159ADNA sequences for matrix metalloproteases, their production and useMAX DELBRUECK CENTRUM·Filed 1995·Granted Sep 5, 2000·13 cites·15 claims
- 1455US2004101888A1Vector system used in screening active substancesMAX DELBRUECK CENTRUM·Filed 2003·Application pending·0 cites
- 1552US2009197851A1Therapy and use of compounds in therapyMAX DELBRUECK CENTRUM·Filed 2008·Application pending·0 cites
- 1648US2009105186A1Beta-L-N4-Hydroxycytosine Deoxynucleosides and their use as Pharmaceutical Agents in the Prophylaxis or Therapy of Viral DiseasesMAX DELBRUECK CENTRUM·Filed 2005·Application pending·0 cites
- 1747US7745139B1Peptides of the AT1 receptor and their usesMAX DELBRUECK CENTRUM·Filed 1999·Granted Jun 29, 2010·11 cites·12 claims
- 1847US2009023662A1Identification of Agonistic Autoantibodies Associated with Humoral Kidney RejectionMAX DELBRUECK CENTRUM·Filed 2007·Application pending·0 cites
- 1946US5888821ACholesterol derivative for liposomal gene transferMAX DELBRUECK CENTRUM·Filed 1995·Granted Mar 30, 1999·10 cites·4 claims
- 2044US6692913B1Process for determining cell vitalityMAX DELBRUECK CENTRUM·Filed 2000·Granted Feb 17, 2004·0 cites·6 claims
- 2143US6489495B2Cationic amphiphiles for liposomal gene transferMAX DELBRUECK CENTRUM·Filed 2001·Granted Dec 3, 2002·0 cites·1 claims
- 2243US2009220469A1Peptides against autoantibodies associated with glaucoma and use of these peptidesMAX DELBRUECK CENTRUM·Filed 2007·Application pending·0 cites
- 2342US7462703B2Agent for gene transferMAX DELBRUECK CENTRUM·Filed 2003·Granted Dec 9, 2008·0 cites·28 claims
- 2442US2008008687A1Transposon-Based Targeting SystemMAX DELBRUECK CENTRUM·Filed 2004·Application pending·0 cites
- 2540US6268516B1Cationic amphiphilic lipids for liposomal gene transferMAX DELBRUECK CENTRUM·Filed 1997·Granted Jul 31, 2001·4 cites·3 claims
- 2640US2008292550A1Fluorinated 3'-Deoxythymidine Derivatives, a Method for Their Preparation and Their UseMAX DELBRUECK CENTRUM·Filed 2006·Application pending·0 cites
- 2739US2001039263A1Chimeric oligonucleotides and the use thereofMAX DELBRUECK CENTRUM·Filed 2001·Application pending·0 cites
- 2838US2011189141A1Multiple target t cell receptorMAX DELBRUECK CENTRUM·Filed 2010·Application pending·0 cites
- 2937US7951927B2Reconstructed human mariner transposon capable of stable gene transfer into chromosomes in vertebratesMAX DELBRUECK CENTRUM·Filed 2006·Granted May 31, 2011·0 cites·26 claims
- 3036US2016008339A1Psoralen derivatives for preventing or treating heart failure or cardiac hypertrophyMAX DELBRUECK CENTRUM·Filed 2013·Application pending·0 cites
- 3133US2006110332A1Agent for medicamentous treatment of acute and chronic painMAX DELBRUECK CENTRUM·Filed 2003·Application pending·0 cites
- 3230US6683172B1Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapyMAX DELBRUECK CENTRUM·Filed 1999·Granted Jan 27, 2004·5 cites·12 claims
- 3329US7556827B1Implantable active ingredient depotMAX DELBRUECK CENTRUM·Filed 2000·Granted Jul 7, 2009·0 cites·2 claims
- 3426US6582690B1Process for treating tumors with cytotoxic substancesMAX DELBRUECK CENTRUM·Filed 1999·Granted Jun 24, 2003·0 cites·5 claims
- 3523US6756197B1Collagenase 3 as a prognostic marker for rheumatoid arthritisMAX DELBRUECK CENTRUM·Filed 2000·Granted Jun 29, 2004·0 cites·11 claims
- 3622US2013300410A1Method for fast spin-echo MRT imagingMAX DELBRUECK CENTRUM·Filed 2013·Application pending·0 cites
- 3721US6177255B1Method for detecting a hormone or antihormone resistance in cancersMAX DELBRUECK CENTRUM·Filed 1997·Granted Jan 23, 2001·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when MAX DELBRUECK CENTRUM files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →